Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

WHO Warns of Growing Global Resistance to Common Antibiotics Medicine

WHO Warns of Growing Global Resistance to Common Antibiotics

  • 14 October 2025
  • 2 weeks ago

Antiplatelet therapy type Has Minimal Impact on Outcomes After Valve-in-Valve TAVR: Study Medicine

Antiplatelet therapy type Has Minimal Impact on Outcomes After Valve-in-Valve TAVR: Study

  • 14 October 2025
  • 2 weeks ago

Early Formula Feeding Linked to Higher Peanut Allergy Risk: Study Medicine

Early Formula Feeding Linked to Higher Peanut Allergy Risk: Study

  • 14 October 2025
  • 2 weeks ago

Epidural Analgesia Lowers Risk of Severe Perineal Tears in First-Time Mothers: Study Medicine

Epidural Analgesia Lowers Risk of Severe Perineal Tears in First-Time Mothers: Study

  • 14 October 2025
  • 2 weeks ago

Two-Dose Recombinant Shingles Vaccine Remains Effective Despite Prior Live Vaccine Use Medicine

Two-Dose Recombinant Shingles Vaccine Remains Effective Despite Prior Live Vaccine Use

  • 14 October 2025
  • 2 weeks ago

POTS common in patients with long COVID: Study Medicine

POTS common in patients with long COVID: Study

  • 14 October 2025
  • 2 weeks ago

Marstacimab Shows Promising Efficacy in Hemophilia Management: Study Medicine

Marstacimab Shows Promising Efficacy in Hemophilia Management: Study

  • 14 October 2025
  • 2 weeks ago

FDA Expands UZEDY Approval to Bipolar I Disorder Medicine

FDA Expands UZEDY Approval to Bipolar I Disorder

  • 13 October 2025
  • 2 weeks ago

Targeted Indoor Spraying Shows No Significant Reduction in Aedes-Borne Disease Incidence: NEJM Medicine

Targeted Indoor Spraying Shows No Significant Reduction in Aedes-Borne Disease Incidence: NEJM

  • 13 October 2025
  • 2 weeks ago

Telitacicept Effectively Reduces Proteinuria in IgA Nephropathy with Safe Tolerability: Study Medicine

Telitacicept Effectively Reduces Proteinuria in IgA Nephropathy with Safe Tolerability: Study

  • 13 October 2025
  • 2 weeks ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Aggressive Risk Factor Management Reduces AF Recur...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.